跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,953 条关于
“Hong Kong King-Friend Industry”
全部
17,953
临床试验
9,995
药物
345
机构
487
资讯
7,126
去年
Meitheal Pharmaceuticals Launches Generic Abraxane in US Market to Address Cancer Treatment Access
5个月前
Hong Kong Launches Primary Evaluation System for Independent Drug Approval
去年
Hong Kong Streamlines Drug Registration Process with New Consultation Services
去年
Hong Kong Launches First Clinical Trial Institute, Prioritizes HIV Vaccine Research
去年
Kadimastem Secures Hong Kong Patent for IsletRx Stem Cell Diabetes Therapy
去年
Hengrui Pharmaceuticals Aims to Raise $1.27 Billion in Hong Kong IPO
去年
Greater Bay Area International Clinical Trial Institute Opens in Hong Kong
去年
Hong Kong Achieves First Myeloma CAR-T Treatment Using Mainland-Manufactured Therapy
去年
Hong Kong Approves Four New Drugs Under Accelerated "1+" Mechanism, Including IgA Nephropathy Treatment
去年
Eli Lilly's Tirzepatide (Mounjaro) Approved in Hong Kong for Weight Management and Type 2 Diabetes
第 1 页，共 713 页
上一页
下一页
